| |
| |
|
| Insider
Information: |
Barrett Peter |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
4,664,922 |
|
|
Indirect Shares
|
23,288,256 |
|
|
| Direct
Value |
$7,539,835 |
|
|
|
Indirect Value
|
$7,995,967 |
|
|
| Total
Shares |
27,953,178 |
|
|
| Total
Value |
$15,535,802 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 40.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2005-09-29 |
189 |
2006-03-07 |
5,293 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Director, 10% Owner |
2004-06-21 |
0 |
2005-08-03 |
379 |
Premium* |
|
|
Helicos Biosciences Corp |
HLCSQ |
Director, 10% Owner |
2007-05-30 |
0 |
2009-09-18 |
11,851,387 |
Premium* |
|
|
Sciclone Pharmaceuticals Inc |
SCLN |
Director |
|
0 |
2011-04-18 |
1,972,189 |
Premium* |
|
|
Perkinelmer Inc |
PKI |
|
2023-05-15 |
21,406 |
2012-05-01 |
0 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Director, 10% Owner |
2016-01-25 |
4,643,327 |
2014-06-24 |
5,632,730 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
Director |
2014-09-29 |
0 |
2014-09-29 |
1,174,315 |
Premium* |
|
|
Synlogic Inc |
SYBX |
Director |
|
0 |
2017-08-28 |
2,651,963 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PKI |
Perkinelmer Inc |
|
– • – |
2023-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,738 |
21,406 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,354 |
19,668 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2021-07-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
18,314 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,313 |
23,314 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2020-05-28 |
4 |
S |
$100.11 |
$756,038 |
D/D |
(7,552) |
22,001 |
0 |
% |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2020-05-28 |
4 |
OE |
$42.09 |
$199,904 |
D/D |
4,750 |
29,552 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$27,476 |
D/D |
2,301 |
24,803 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2019-11-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
955 |
22,502 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2019-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,828 |
23,457 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2019-02-13 |
4 |
S |
$93.62 |
$524,371 |
D/D |
(5,601) |
21,629 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2019-02-13 |
4 |
OE |
$30.51 |
$170,887 |
D/D |
5,601 |
27,630 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,429 |
21,629 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2017-11-13 |
4 |
S |
$71.07 |
$502,564 |
D/D |
(7,071) |
19,200 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2017-11-13 |
4 |
OE |
$27.79 |
$196,468 |
D/D |
7,071 |
26,271 |
0 |
- |
|
| SYBX |
Synlogic Inc |
Director |
– • – |
2017-08-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,651,963 |
|
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2017-06-01 |
4 |
S |
$63.22 |
$632,230 |
D/D |
(10,000) |
19,200 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2017-06-01 |
4 |
OE |
$26.15 |
$261,450 |
D/D |
10,000 |
29,200 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2017-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,802 |
19,200 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2016-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,194 |
16,398 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Director |
– • • |
2016-01-25 |
4 |
A |
$7.91 |
$69,996 |
D/D |
8,849 |
4,643,327 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2015-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,033 |
13,204 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Director |
– • • |
2015-01-08 |
4 |
A |
$40.04 |
$69,990 |
D/D |
1,748 |
5,634,478 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Director |
– • – |
2014-09-29 |
4 |
B |
$8.00 |
$300,000 |
I/I |
37,500 |
1,174,315 |
2.1 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Director |
– • – |
2014-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,136,815 |
1,136,815 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Director |
– • – |
2014-06-24 |
4 |
A |
$0.00 |
$0 |
I/I |
5,632,730 |
5,632,730 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
